AbbVie Leads Injectables Boom Towards $19 Billion by 2029

This episode explores the rapidly expanding world of facial injectables, projected to reach nearly $19 billion by 2029. Driven by a trend towards non-invasive beauty solutions and an aging population, the sector has seen significant contributions from key players like AbbVie and Evolus. The podcast discusses market dynamics, such as the prominence of dermal fillers and Botulinum toxin, while also addressing the challenges of adverse effects and regulations faced by the industry. Additionally,...